The information on this website about treatment with Saxenda® (liraglutide injection 3mg) for weight loss in addition to diet and exercise is intended for people who have already been prescribed Saxenda®. If you are a member of the public or a UK healthcare professional, please visit the relevant section:
All content of this Internet site is the property of Novo Nordisk A/S, and is protected by copyright laws. You may download content only for your personal use for non-commercial purposes, but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any manner. The trademarks, service marks, trade names, and products displayed in this Internet site are protected worldwide and no use of any of these may be made without the prior written consent of Novo Nordisk A/S.